Chemical warfare agents.

Chemical warfare agents (CWA's) are defined as any chemical substance whose toxic properties are utilised to kill, injure or incapacitate an enemy in warfare and associated military operations. Chemical agents have been used in war since times immemorial, but their use reached a peak during World War I. During World War II only the Germans used them in the infamous gas chambers. Since then these have been intermittently used both in war and acts of terrorisms. Many countries have stockpiles of these agents. There has been a legislative effort worldwide to ban the use of CWA's under the chemical weapons convention which came into force in 1997. However the manufacture of these agents cannot be completely prohibited as some of them have potential industrial uses. Moreover despite the remedial measures taken so far and worldwide condemnation, the ease of manufacturing these agents and effectiveness during combat or small scale terrorist operations still make them a powerful weapon to reckon with. These agents are classified according to mechanism of toxicity in humans into blister agents, nerve agents, asphyxiants, choking agents and incapacitating/behavior altering agents. Some of these agents can be as devastating as a nuclear bomb. In addition to immediate injuries caused by chemical agents, some of them are associated with long term morbidities and psychological problems. In this review we will discuss briefly about the historical background, properties, manufacture techniques and industrial uses, mechanism of toxicity, clinical features of exposure and pharmacological management of casualties caused by chemical agents.

[1]  William J Smith,et al.  Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard , 1993, Cell Biology and Toxicology.

[2]  F. Menger,et al.  Rapid deactivation of mustard via microemulsion technology , 1990 .

[3]  Tetsu Okumura,et al.  Asymptomatic sequelae to acute sarin poisoning in the central and autonomic nervous system 6 months after the Tokyo subway attack , 1997, Journal of Neurology.

[4]  J. McDonough,et al.  Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs , 1999, Epilepsy Research.

[5]  S. Woods,et al.  Occupational arsine gas exposure. , 2006, Journal of the National Medical Association.

[6]  D. Penney,et al.  Cyanide poisoning in animals and humans: a review. , 1994, Veterinary and human toxicology.

[7]  T Okumura,et al.  Report on 640 victims of the Tokyo subway sarin attack. , 1996, Annals of emergency medicine.

[8]  Paul Rice,et al.  Regular review: Chemical weapons , 2002 .

[9]  Charles W. Mushett,et al.  Antidotal Efficacy of Vitamin B12a (Hydroxo-Cobalamin) in Experimental Cyanide Poisoning , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  J. McDonough Performance Impacts of Nerve Agents and Their Pharmacological Countermeasures , 2002 .

[11]  E Raber,et al.  Decontamination issues for chemical and biological warfare agents: How clean is clean enough? , 2001, International journal of environmental health research.

[12]  B. Mégarbane,et al.  Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. , 2007, The American journal of emergency medicine.

[13]  G. F. Marrian,et al.  The action of arsine on blood: Observations on the nature of the fixed arsenic. , 1946, The Biochemical journal.

[14]  R. Fleischman,et al.  Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL. , 1946, The Journal of clinical investigation.

[15]  R. C. Malhotra,et al.  Reaction of elemental sulfur in ethylenediamine with sulfur mustard , 2005 .

[16]  F. Oehme British anti-lewisite (BAL), the classic heavy metal antidote. , 1972, Clinical toxicology.

[17]  S. Langermann,et al.  Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning , 2007, Proceedings of the National Academy of Sciences.

[18]  M. Ghassemi-Broumand,et al.  The Delayed Ocular and Pulmonary Complications of Mustard Gas , 2004 .

[19]  S. Baskin,et al.  The Pharmacology of p-Aminopropiophenone in the Detoxification of Cyanide , 1992 .

[20]  W. Diller Therapeutic Strategy in Phosgene Poisoning , 1985, Toxicology and industrial health.

[21]  N. Greig,et al.  In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger. , 2005, Chemico-biological interactions.

[22]  P. Blanc,et al.  Chlorine Gas Exposure and the Lung: A Review , 1993, Toxicology and industrial health.

[23]  K. Yokoyama,et al.  Clinical profiles of patients with sarin poisoning after the Tokyo subway attack. , 1996, The American journal of medicine.

[24]  J. Petrali,et al.  Molecular basis for mustard-induced vesication. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[25]  J. Mellors,et al.  Arteriolization of venous blood gases: a clue to the diagnosis of cyanide poisoning. , 1988, The Journal of emergency medicine.

[26]  G. Braitberg,et al.  Treatment of cyanide poisoning in Australasia , 2000 .

[27]  W G Eckert Mass deaths by gas or chemical poisoning. A historical perspective. , 1991, The American journal of forensic medicine and pathology.

[28]  R. Braithwaite,et al.  The metabolic effects of fatal cyanide poisoning. , 1989, Postgraduate medical journal.

[29]  G. E. Quinby FURTHER THERAPEUTIC EXPERIENCE WITH PRALIDOXIMES IN ORGANIC PHOSPHORUS POISONING. , 1964, JAMA.

[30]  T. Shih,et al.  Comparative evaluation of benzodiazepines for control of soman-induced seizures , 1999, Archives of Toxicology.

[31]  K. Kulig Cyanide antidotes and fire toxicology. , 1991, The New England journal of medicine.